CoChat

Δ9‐Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats

Open access
Hill, Andrew J., Weston, Samantha E., Jones, Nicholas A., Smith, Imogen, Bevan, Sarah A., Williamson, Elizabeth M., Stephens, Gary J., Williams, Claire M., Whalley, Benjamin J. · 2010 · Epilepsia
Cited by 119

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Purpose: We assessed the anticonvulsant potential of the phytocannabinoid Δ 9‐tetrahydrocannabivarin (Δ 9‐THCV) by investigating its effects in an in vitro piriform cortex (PC) brain slice model of epileptiform activity, on cannabinoid CB1 receptor radioligand‐binding assays and in a generalized seizure model in rats. Methods: Δ 9‐THCV was applied before (10 μ m Δ 9‐THCV) or during (10–50 μ m Δ 9‐THCV) epileptiform activity induced by Mg 2+‐free extracellular media in adult rat PC slices and measured using multielectrode array (MEA) extracellular electrophysiologic techniques. The actions of Δ 9‐THCV on CB1 receptors were examined using [3 H]SR141716A competition binding and [35 S]GTPγS assays in rat cortical membranes. Effects of Δ 9‐THCV (0.025–2.5 mg/kg) on pentylenetetrazole (PTZ)–induced seizures in adult rats were also assessed. Results: After induction of stable spontaneous epileptiform activity, acute Δ 9‐THCV application (≥20 μ m) significantly reduced burst complex incidence and the amplitude and frequency of paroxysmal depolarizing shifts (PDSs). Furthermore, slices pretreated with 10 μ m Δ 9‐THCV prior to induction of epileptiform activity exhibited significantly reduced burst complex incidence and PDS peak amplitude. In radioligand‐binding experiments, Δ 9‐THCV acted as a CB1 receptor ligand, displacing 0.5 n m[3 H]SR141716A with a Ki∼290 n m, but exerted no agonist stimulation of [35 S]GTPγS binding. In PTZ‐induced seizures in vivo, 0.25 mg/kg Δ 9‐THCV significantly reduced seizure incidence. Discussion: These data demonstrate that Δ 9‐THCV exerts antiepileptiform and anticonvulsant properties, actions that are consistent with a CB1 receptor–mediated mechanism and suggest possible therapeutic application in the treatment of pathophysiologic hyperexcitability states.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1528-1167.2010.02523.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 119

Metadata

Authors
Hill, A. J., Weston, S. E., Jones, N. A., Smith, I., Bevan, S. A., Williamson, E. M., Stephens, G. J., Williams, C. M., & Whalley, B. J.
Venue
Epilepsia
Publisher
Wiley
Published
2010-08
Volume
51
Issue
8
Pages
1522-1532
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W1937321014
Cited by
119
References
3
FWCI
3.07
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Δ9‐Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats. https://app.cochat.ai/papers/10.1111/j.1528-1167.2010.02523.x
The paper
Hill, A. J., Weston, S. E., Jones, N. A., Smith, I., Bevan, S. A., Williamson, E. M., Stephens, G. J., Williams, C. M., & Whalley, B. J. (2010). Δ9‐Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02523.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.